v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net increase (decrease) in net assets resulting from operations $ 97,314 $ 186,382
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change in unrealized (appreciation) depreciation on investments 283,305 (69,458)
Net realized (gain) loss on investments (15,221) 19,886
Net change in unrealized (appreciation) depreciation on foreign currency forward contracts (29,116) 24,102
Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies (28,364) 38,257
Net accretion of discount and amortization of premium, net (24,953) (18,205)
Amortization of deferred financing costs 3,004 2,394
Amortization of original issue discount and debt issuance costs 7,116 4,462
Amortization of offering costs 705 532
Payment-in-kind interest capitalized (34,927) (24,183)
Payment-in-kind dividends capitalized (1,310) (1,131)
Purchases of investments (1,509,178) (2,502,618)
Proceeds from sale of investments and principal repayments 1,631,851 296,405
Changes in operating assets and liabilities:    
Interest receivable from non-controlled/non-affiliated investments 8,996 (5,733)
Interest receivable from non-controlled/affiliated investments (577) (175)
Dividend receivable from non-controlled/non-affiliated investments (4) 65
Receivable for investments (213,992) (46,577)
Other assets (7,591) 10,563
Payable for investments purchased (259) 50,041
Interest payable (26,209) (14,453)
Due to affiliates (1,884) 3
Management fees payable 12,723 10,216
Income based incentive fees payable (1,299) 1,714
Capital gains incentive fees payable 0 (6,038)
Shareholder servicing and/or distribution fees payable 5 206
Accrued expenses and other liabilities (42,386) 15,875
Net cash provided by (used in) operating activities 107,749 (2,027,468)
Cash flows from financing activities:    
Borrowings on debt 2,770,210 5,151,226
Repayments of debt (2,784,569) (3,713,069)
Deferred financing costs paid (7,405) (301)
Debt issuance costs and original issue discount paid (11,850) (30,770)
Deferred offering costs paid (618) (184)
Proceeds from issuance of Common Shares 720,054 1,067,398
Common Shares repurchased, net of early repurchase deduction (479,226) (110,784)
Distributions paid in cash (201,598) (130,640)
Net cash provided by (used in) financing activities 4,998 2,232,876
Net increase (decrease) in cash and cash equivalents 112,747 205,408
Cash and cash equivalents, beginning of period 590,666 228,899
Cash and cash equivalents, end of period 703,413 434,307
Supplemental information and non-cash activities:    
Interest paid during the period 204,873 145,503
Taxes paid during the period 7,180 5,428
Distribution payable 107,321 80,511
Share repurchases accrued but not paid 610,738 210,394
Reinvestment of distributions during the period 118,045 91,917
Non-cash purchases of investments 16,723 17,850
Non-cash sales of investments $ (16,723) $ (17,850)